Two Sigma Advisers
CLVS

Two Sigma Advisers’s Clovis Oncology, Inc. CLVS Stock Holding History

Two Sigma Advisers’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-49,400
Closed -$89K – 2805
2022
Q2 		$89K Sell
49,400
-69,100
-58% -$102K ﹤0.01% 2400
2022
Q1 		$239K Sell
118,500
-106,400
-47% -$209K ﹤0.01% 2326
2021
Q4 		$609K Buy
224,900
+159,000
+241% +$588K ﹤0.01% 1818
2021
Q3 		$294K Buy
+65,900
New +$317K ﹤0.01% 2129
2020
Q2 		– Sell
-25,100
Closed -$160K – 2637
2020
Q1 		$160K Buy
+25,100
New +$201K ﹤0.01% 2222
2019
Q4 		– Sell
-743,706
Closed -$2.92M – 2510
2019
Q3 		$2.92M Buy
743,706
+686,400
+1,198% +$5.55M 0.01% 971
2019
Q2 		$852K Buy
57,306
+35,106
+158% +$634K ﹤0.01% 1600
2019
Q1 		$551K Buy
+22,200
New +$557K ﹤0.01% 1755
2018
Q1 		– Sell
-48,400
Closed -$3.29M – 2455
2017
Q4 		$3.29M Buy
+48,400
New +$3.38M 0.01% 1020
2017
Q3 		– Sell
-4,700
Closed -$440K – 2386
2017
Q2 		$440K Sell
4,700
-9,200
-66% -$563K ﹤0.01% 1836
2017
Q1 		$885K Buy
+13,900
New +$845K ﹤0.01% 1646
2016
Q1 		– Sell
-27,601
Closed -$966K – 2171
2015
Q4 		$966K Buy
27,601
+17,195
+165% +$1.11M 0.01% 1036
2015
Q3 		$957K Buy
+10,406
New +$901K 0.01% 1024
2014
Q3 		– Sell
-12,806
Closed -$530K – 2744
2014
Q2 		$530K Buy
+12,806
New +$660K ﹤0.01% 1643

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Two Sigma Advisers's CLVS Position: Q3 2022 in Review

Two Sigma Advisers sold out of Clovis Oncology, Inc. (CLVS) in Q3 2022, closing a stake of 49,400 shares — an estimated $89K sold.

Two Sigma Advisers first reported a position in CLVS in Q2 2014 and held it in 14 quarters. The position peaked at $3.29M in Q4 2017. 103 funds tracked by Wall St. Rank hold CLVS as of Q3 2022.

  • Two Sigma Advisers reported no remaining Clovis Oncology, Inc. position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 49,400 Clovis Oncology, Inc. shares in Q3 2022, an estimated $89K.
  • Two Sigma Advisers first reported a position in Clovis Oncology, Inc. in Q2 2014 and held it in 14 quarters.
  • Two Sigma Advisers's Clovis Oncology, Inc. position peaked at $3.29M in Q4 2017.
  • 103 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2022.

Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.